Anavex Life Sciences Corp (AVXL)

[bas2020]

The below link is to a report on all of the current Alz trials listed on clinicaltrials.gov, as of Jan 4, 2016, identifying all 93 agents, their MoAs and their various trials and stages (Phase I, II, III).

It's worth noting that 2-73 is the ONLY agent identified with an MoA of "Sigma-1 Receptor Agonist".

http://www.trci.alzdem.com/article/S2352-8737(16)30019-1/pdf